Clinical Trials Directory

Explore 118,444 clinical trials worldwide

Showing 81251-81300 of 118,444 trials

Active filters:Status: Recruiting, Active, not recruiting, Enrolling by invitation, Not yet recruiting

Clinical Trials (118,444)

NCT05225233
tDCS With Cognitive Training to Reduce Impulsivity and Weight in Veterans With Obesity
NARecruiting
124 participants
Started: Nov 23, 2022 · Completed: Apr 30, 2026
1 condition1 sponsor1 location
NCT05412771
Evolutive and Functional Bases of Menstruation in Women - 2
NARecruiting
20 participants
Started: Nov 23, 2022 · Completed: Oct 25, 2027
1 condition1 sponsor1 location
NCT05226455
Venetoclax in Patients With MDS or AML in Relapse After AHSCT
PHASE1/PHASE2Recruiting
55 participants
Started: Nov 23, 2022 · Completed: Dec 1, 2027
2 conditions2 sponsors13 locations
NCT05719116
A Combined Aerobic and Resistance Training Program for Adults With Psychotic Disorders
NAActive, not recruiting
40 participants
Started: Nov 23, 2022 · Completed: Dec 31, 2028
1 condition1 sponsor1 location
NCT05779592
A Study to Evaluate Nivolumab in Japanese Participants With Muscle-invasive Urothelial Carcinoma
N/AActive, not recruiting
400 participants
Started: Nov 23, 2022 · Completed: Sep 30, 2027
1 condition2 sponsors1 location
NCT05364762
Adding Itacitinib to Cyclophosphamide and Tacrolimus for the Prevention of Graft Versus Host Disease in Patients Undergoing Hematopoietic Stem Cell Transplants
PHASE2Active, not recruiting
20 participants
Started: Nov 23, 2022 · Completed: May 22, 2026
7 conditions2 sponsors1 location
NCT05087303
Telemedicine for Children With Sickle Cell Disease
NARecruiting
60 participants
Started: Nov 23, 2022 · Completed: Jan 1, 2026
1 condition2 sponsors1 location
NCT05621746
An Observational Research Study of the Health of Joints in People With Haemophilia Taking the Medicine Esperoct
N/ARecruiting
100 participants
Started: Nov 23, 2022 · Completed: Jun 30, 2026
1 condition1 sponsor1 location
NCT05626621
Efficacy of Azelastine and Mometasone Irrigation in Comparison to Nasal Sprays in Patients With Chronic Rhinitis
PHASE4Recruiting
81 participants
Started: Nov 23, 2022 · Completed: Aug 31, 2026
1 condition1 sponsor1 location
NCT05374603
Savolitinib Combine With Durvalumab in EGFR Wild-type Locally Advanced or Metastatic NSCLC
PHASE2Active, not recruiting
47 participants
Started: Nov 23, 2022 · Completed: Aug 30, 2025
1 condition1 sponsor16 locations
NCT05739084
Gene Signatures Searching of Sensitivity/Resistance to Neoadjuvant Radiotherapy in Patients With Resectable STS
N/ARecruiting
300 participants
Started: Nov 23, 2022 · Completed: Nov 23, 2025
1 condition1 sponsor1 location
NCT05656131
Fluzoparib in Combination With or Without Camrelizumab for Homologous Recombinant Deficiency (HRD) HER2 Negative Advanced Breast Cancer
PHASE2Recruiting
80 participants
Started: Nov 23, 2022 · Completed: Dec 31, 2026
1 condition1 sponsor1 location
NCT05451212
Open-label Study to Evaluate the Safety of Various Dosing Regimens of MuSK-CAART for MuSK Myasthenia Gravis
PHASE1Recruiting
24 participants
Started: Nov 23, 2022 · Completed: Oct 31, 2028
1 condition1 sponsor5 locations
NCT05694559
Connecting Black Families in Houston, Texas to Hereditary Cancer Genetic Counseling, Genetic Testing, and Cascade Testing by Using a Simple Genetic Risk Screening Tool and Telegenetics
NARecruiting
1,000 participants
Started: Nov 23, 2022 · Completed: Feb 2, 2027
2 conditions1 sponsor1 location
NCT06154343
A Study of GQ1005 in Subjects With HER2-Expressing Advanced Solid Tumors
PHASE1Recruiting
150 participants
Started: Nov 23, 2022 · Completed: Jul 30, 2025
1 condition1 sponsor20 locations
NCT05613738
177Lu-PSMA-EB-01 in Patients With Metastatic Castration-resistant Prostate Cancer
NARecruiting
9 participants
Started: Nov 23, 2022 · Completed: Nov 15, 2025
1 condition1 sponsor1 location
NCT05474274
PAIN (Pain AI iNtervention) Platform for Patients at Home
N/AEnrolling by invitation
70 participants
Started: Nov 23, 2022 · Completed: Nov 30, 2027
1 condition1 sponsor1 location
NCT05606692
Influences of Propofol and Sevoflurane Anesthesia in Ovarian Cancer (Anesthetics)
PHASE4Recruiting
416 participants
Started: Nov 23, 2022 · Completed: Sep 30, 2027
1 condition2 sponsors1 location
NCT05965245
Suubi-Mhealth: A Mobile Health Intervention to Address Depression Among Youth
NARecruiting
278 participants
Started: Nov 23, 2022 · Completed: Aug 31, 2027
2 conditions2 sponsors2 locations
NCT05663892
Drug-Drug Interaction Study in Trans Women Living With HIV
PHASE4Active, not recruiting
45 participants
Started: Nov 23, 2022 · Completed: Jan 31, 2025
2 conditions1 sponsor1 location
NCT06313411
How do I Perform a Laparoscopic Removal of a Pelvic Retroperitoneal Schwannoma
N/ARecruiting
1 participants
Started: Nov 23, 2022 · Completed: Apr 30, 2024
1 condition1 sponsor1 location
NCT05619016
[68Ga]Ga-ABY-025 PET for Quantification of HER2-status in Solid Tumors
PHASE2Recruiting
72 participants
Started: Nov 23, 2022 · Completed: Dec 31, 2025
4 conditions1 sponsor1 location
NCT06491082
Chemotherapy Induced Neuropathy in Cancer Patients
N/ARecruiting
124 participants
Started: Nov 23, 2022 · Completed: Aug 25, 2024
1 condition1 sponsor1 location
NCT05788679
A Study Using Subject-specific MRD to Adopt Treatment After HSCT for Subjects With MDS
PHASE2Recruiting
200 participants
Started: Nov 22, 2022 · Completed: Dec 31, 2026
3 conditions2 sponsors1 location
NCT05579548
A Global, Multicenter Study to Assess Maternal, Fetal and Infant Outcomes of Exposure to Palynziq® (Pegvaliase) During Pregnancy and Breastfeeding
N/ARecruiting
50 participants
Started: Nov 22, 2022 · Completed: Oct 4, 2032
1 condition2 sponsors3 locations
NCT05642377
A Study to Investigate the Safety, Tolerability, Pharmacokinetic/Pharmacodynamic Characteristics and Food Effect of HGR4113 in Healthy Subjects
PHASE1Recruiting
40 participants
Started: Nov 22, 2022 · Completed: Jan 31, 2025
1 condition2 sponsors1 location
NCT04954690
Structured Program of Exercise for Recipients of Kidney Transplantation
NARecruiting
136 participants
Started: Nov 22, 2022 · Completed: Jul 31, 2029
4 conditions1 sponsor1 location
NCT05566925
Patients' Perceptions of Assessment and Treatment of Knee Osteoarthritis in Primary Care
N/AActive, not recruiting
15 participants
Started: Nov 22, 2022 · Completed: Jun 30, 2025
1 condition1 sponsor2 locations
NCT05838417
Promoting Informed Choice for Breast Cancer Screening: A Longitudinal Study
NAActive, not recruiting
700 participants
Started: Nov 22, 2022 · Completed: Apr 1, 2026
1 condition2 sponsors2 locations
NCT05351905
Improving Pain Disability With the Use of Oral Cannabinoids
NARecruiting
51 participants
Started: Nov 22, 2022 · Completed: Apr 30, 2026
3 conditions1 sponsor1 location
NCT05629845
Prevention of Variceal Rebleeding by EUS-guided vs Conventional Endoscopic Therapy in Hepatocellular Carcinoma Patients
NARecruiting
84 participants
Started: Nov 22, 2022 · Completed: Dec 31, 2026
2 conditions1 sponsor1 location
NCT05748327
Trial With Two New Tooth-colored Restorative Materials in Class I/II Cavities
NAActive, not recruiting
58 participants
Started: Nov 22, 2022 · Completed: Apr 1, 2028
2 conditions2 sponsors1 location
NCT05272878
Impact of a Treatment With Angiotensin Receptor Blocker on Outcome After Acute Kidney Injury in Patients Discharged From the ICU.
PHASE3Active, not recruiting
508 participants
Started: Nov 22, 2022 · Completed: Jun 27, 2026
1 condition1 sponsor1 location
NCT05628883
Proof of Concept of TBio-4101, Lymphodepleting Chemo, IL-2 for Relapsed/Refractory Melanoma
PHASE1Active, not recruiting
17 participants
Started: Nov 22, 2022 · Completed: Dec 31, 2026
10 conditions2 sponsors1 location
NCT05708716
Diet and Cognitive Training in Hematologic Cancer Survivors
NARecruiting
80 participants
Started: Nov 22, 2022 · Completed: Apr 30, 2026
2 conditions2 sponsors1 location
NCT05598424
CST1 Predictive Model of Oral Glucocorticoid Therapy Sensitivity for Chronic Rhinosinusitis With Polyps
PHASE4Recruiting
150 participants
Started: Nov 22, 2022 · Completed: Nov 1, 2025
2 conditions1 sponsor1 location
NCT05500339
Effectiveness of a mHealth App for Supporting the First 1000 Days of Life
NARecruiting
360 participants
Started: Nov 22, 2022 · Completed: Dec 31, 2024
1 condition1 sponsor1 location
NCT06218511
A Phase I Trial of IMA970A Plus Montanide in Combination With Durvalumab (Anti-PD-L1)
PHASE1Recruiting
10 participants
Started: Nov 22, 2022 · Completed: Nov 30, 2026
1 condition1 sponsor1 location
NCT05341817
The Use of Letrozole or Mifepristone for Pretreatment of Medical Termination of Pregnancy
PHASE4Recruiting
144 participants
Started: Nov 22, 2022 · Completed: Nov 30, 2025
1 condition1 sponsor1 location
NCT05247502
Impact of the Characteristics of Acute Renal Failure in Intensive Care on the Long-term Renal Prognosis: Prospective Multicenter Cohort Study
N/ARecruiting
860 participants
Started: Nov 22, 2022 · Completed: Nov 1, 2028
3 conditions1 sponsor2 locations
NCT05617508
N-DOSE AD: a Dose Optimization Trial of Nicotinamide Riboside in Alzheimer's Disease
PHASE2Active, not recruiting
80 participants
Started: Nov 22, 2022 · Completed: Oct 31, 2025
2 conditions2 sponsors2 locations
NCT04575883
HIIT in Youth With Congenital Heart Disease (MedBIKE)
NARecruiting
44 participants
Started: Nov 22, 2022 · Completed: Dec 31, 2026
2 conditions2 sponsors1 location
NCT06155916
Sleep and Neuropathic Pain - Intervention Study on Pregabalin
NARecruiting
40 participants
Started: Nov 22, 2022 · Completed: Dec 31, 2026
3 conditions2 sponsors2 locations
NCT06051942
PRCT001 Aquablation theraPy Outcomes in pRostate Cancer patienTs
NARecruiting
125 participants
Started: Nov 22, 2022 · Completed: May 31, 2026
2 conditions1 sponsor7 locations
NCT05239793
Electronic Cigarette-derived Oxidants and Cardiopulmonary Effects
EARLY_PHASE1Recruiting
30 participants
Started: Nov 22, 2022 · Completed: Jun 30, 2025
1 condition2 sponsors1 location
NCT07082257
Precision Performance Status Compared With ECOG Performance Status
N/AActive, not recruiting
41 participants
Started: Nov 22, 2022 · Completed: May 28, 2026
2 conditions2 sponsors2 locations
NCT05602493
A Randomized Control Trial Phase (IIIa) Unicentric, Placebo Controlled, Double-Blinded Efficacy and Safety of Topical Alendronic Acid on Alveolar Bone Remodeling After Tooth Extraction
PHASE3Active, not recruiting
60 participants
Started: Nov 22, 2022 · Completed: Oct 20, 2024
1 condition1 sponsor1 location
NCT05583734
A Prospective Study of Conventional Bone Marrow Biopsy Versus Portomar(TM) Biopsy
NARecruiting
32 participants
Started: Nov 22, 2022 · Completed: Oct 31, 2025
1 condition1 sponsor1 location
NCT05346068
The Value of IVL Compared To OPN Non-Compliant Balloons for Treatment of RefractorY Coronary Lesions (VICTORY) Trial
NARecruiting
280 participants
Started: Nov 22, 2022 · Completed: May 30, 2028
5 conditions3 sponsors1 location
NCT05488873
A Study of Topical Pirenzepine or Placebo in Oncology Patients With Chemotherapy Induced Peripheral Neuropathy
PHASE2Active, not recruiting
60 participants
Started: Nov 22, 2022 · Completed: May 30, 2026
1 condition1 sponsor1 location